中西医结合治疗病毒性肝炎高胆红素血症的成本效益分析

Cost-benefit analysis of treating hyperbilirubinemia caused by viral hepatitis in the integrative medicine

目的:观察中西医结合治疗病毒性肝炎高胆红素血症的临床疗效,并进行成本效益分析。方法:对照组予西药治疗,治疗组在对照组治疗的基础上加用赤红活血退黄汤治疗。两组患者治疗前后检测肝功能指标,同时观察临床症状变化情况,统计患者住院天数、住院费用情况。结果:临床总有效率治疗组为81.63%,对照组为65%,2组比较,差异有显著性意义(P<0.05)。出院时治疗组费用为(35541.51±36842.58)元,对照组费用为(46456.42±38250.31)元,住院天数,治疗组为(34.29±11.33),对照组为(41.93±10.83),两者比较,有显著性差异(P<0.05)。结论:中西医结合治疗病毒性肝炎高胆红素血症,其疗效及预后明显优于单纯使用西药治疗,住院费用、住院天数明显低于对照组。

Objective：To observe the clinical effect of treating hyperbilirubinemia casused by viral hepatitis in the integrative medicine and do a cost-benefit analysis.Methods：Control group were treated with Western medicine,based on that,control group applying Chihong Huoxue Tuihuang decoction.Checking liver function indexes of the two groups before and after treatment,meanwhile,observe changes in clinical symptoms;make statistics of hospitalizaition days and expenses.Results：Total therapeutic efficacy in control group and treatment group were 81.63%and 65%,then compared two groups,which had obviously meaning（P0.05）.Hospitalization expenses in treatment group and control group were（35541.51±36842.58）RMB and（46456.42±38250.31）RMB,while hospitalization days in treatment group and control group were（34.29±11.33）days and（41.93±10.83）days,compared these,which also had obviously difference（P0.05）.Conclusion：The effect and prognosis of treating hyperbilirubinemia caused by viral hepatitis in the integrative medicine was obviously better than only using Western medicine,and hospitalization days and expenses of treatment group were obviously less than control group.